Autosomal Dominant Axonal Charcot-Marie-Tooth Disease Type 2U (CMT2U)

Autosomal dominant axonal Charcot-Marie-Tooth disease type 2U (CMT2U) is a rare inherited nerve disease that mainly damages the “axons” of the peripheral nerves, which are the long wires that carry signals to and from the muscles and skin. In CMT2U, symptoms usually start in late adult life (often between 50 and 60 years of age) and slowly get worse over many years. People develop weakness and thinning of muscles in the hands and lower legs, together with loss of feeling (sensory loss) in the feet and hands. Reflexes are often reduced or absent, and nerve conduction tests show axonal damage. Orpha.net+2MalaCards+2

Autosomal dominant axonal Charcot-Marie-Tooth disease type 2U (CMT2U) is a very rare inherited nerve disease. It mainly damages the long peripheral nerves that carry signals to and from the hands and feet. People usually develop symptoms in later adult life (often around 50–60 years). They slowly develop numbness, tingling, weakness, and muscle wasting in the feet, legs, hands, and sometimes forearms.NCBI+2Orpha.net+2

CMT2U is “autosomal dominant,” which means a change in only one copy of the gene can cause the disease, and each child of an affected parent has a 50% chance to inherit it. In many people, the cause is a mutation in the MARS gene, which makes an enzyme (methionyl-tRNA synthetase) important for building proteins in nerve cells. Faulty MARS leads to axonal damage (injury to the long part of the nerve), so signals move more slowly or are blocked.SAGE Journals+1

CMT2U follows an autosomal dominant pattern, which means a change (mutation) in just one copy of the responsible gene is enough to cause the disease. It is one of many subtypes of Charcot-Marie-Tooth disease type 2 (CMT2), the group of CMT conditions in which the main problem is axonal injury rather than damage to the myelin covering around the nerve. In most reported families, life span is not shortened, but disability and pain can affect quality of life and daily activities. Charcot-Marie-Tooth Association+2NCBI+2

Other names

CMT2U has several other names used in medical books and rare-disease databases. Knowing these names helps when searching the literature or medical records, because different authors may use different terms for the same condition. ZFIN+1

Doctors and researchers may call this disease:

• Autosomal dominant axonal Charcot-Marie-Tooth disease type 2U

• Autosomal dominant Charcot-Marie-Tooth disease type 2U

• Charcot-Marie-Tooth neuropathy type 2U

• CMT2U

• Autosomal dominant CMT type 2 due to MARS mutation

All of these names describe the same disorder and point to the same key idea: a dominantly inherited axonal CMT caused by a mutation in the MARS gene. ZFIN+2Global Genes+2

Types

CMT2U itself is a “type” or subtype within the wider CMT2 family, but the few published reports show that its clinical picture can vary between people and even within the same family. Because it is so rare, there is no official list of strict subtypes, but doctors do recognize some clinical patterns inside CMT2U. Orpha.net+2MalaCards+2

Some patterns that have been described are:

• Typical late-onset CMT2U – This is the most common pattern. Symptoms start in late adulthood (around 50–60 years). People first notice numbness or tingling in the feet and weakness in the hands or ankles. The problem then slowly spreads up the legs and arms over many years. Orpha.net+1

• Early-onset or congenital CMT2U – A few reports describe children with very early onset, sometimes from birth, who have a mutation in the same MARS gene. These children may show delayed motor milestones and early weakness, which tells us that CMT2U can sometimes appear much earlier than usual. Institut Myologie+1

• CMT2U with strong neuropathic pain – Some adults with CMT2U mainly complain of burning, shooting, or electric-like pain in the feet and legs, in addition to weakness and numbness. In others, pain is mild or absent. This shows how the same genetic condition can affect pain pathways differently in different people. MalaCards+1

• CMT2U with mainly hand weakness – In several families, weakness of the small muscles in the hands (for example difficulty with buttons or keys) is more obvious than foot problems at the beginning. This pattern fits with the description of distal upper-limb weakness that has been reported in CMT2U cases. MalaCards+1

These patterns are ways that doctors describe patients in practice; they are not separate diseases. The same MARS mutation can produce different severity and symptom mixes in different people. ZFIN+1

Causes

In this section, “causes” means the main genetic reason for CMT2U and the biological mechanisms that lead from the gene change to nerve damage. For a single-gene disease like CMT2U, there is one primary cause (the mutation), and many linked mechanisms and modifiers that influence how the disease appears. NCBI+1

1. Pathogenic mutation in the MARS gene
   The core cause of CMT2U is a harmful change in one copy of the MARS gene on chromosome 12. MARS encodes methionyl-tRNA synthetase, an enzyme needed for normal protein building in cells. When this gene is mutated, the enzyme does not work correctly, and peripheral nerves are especially sensitive to this problem. ZFIN+1

2. Autosomal dominant inheritance
   CMT2U is usually inherited in an autosomal dominant way. This means a person who carries one mutated copy of MARS in each cell has a high chance of developing the disease and a 50% chance of passing the mutation to each child. Family history of a similar neuropathy is therefore a strong clue. Orpha.net+2Global Genes+2

3. De novo MARS mutation
   Sometimes a person with CMT2U has no affected parent. In these cases, the mutation can arise “de novo,” which means it appears for the first time in that person, likely during egg or sperm formation or early embryo development. The new mutation can then be passed on to their children in a dominant pattern. NCBI+1

4. Loss of normal methionyl-tRNA synthetase function
   The methionyl-tRNA synthetase enzyme links the amino acid methionine to its transfer RNA, a key step in making new proteins. A mutation may reduce this activity, especially in long peripheral neurons that need constant protein supply to maintain their very long axons. This chronic shortage can make axons gradually fail. Institut Myologie+1

5. Toxic gain-of-function of mutant MARS protein
   Some studies of aminoacyl-tRNA synthetase–related neuropathies suggest that mutated enzymes may gain harmful new properties, such as abnormal binding to other proteins or mislocalization in the cell. This toxic gain-of-function can stress neurons in addition to any loss of normal function. SAGE Journals+1

6. Impaired protein synthesis in peripheral neurons
   Because MARS is directly involved in protein production, its dysfunction can slow or disturb protein synthesis in peripheral nerves. Axons rely on a steady flow of new proteins; when this is blocked, their internal transport systems weaken and the axon gradually degenerates, especially at the far ends. NCBI+1

7. Disturbed axonal transport
   Long axons, such as those to the feet, need to move nutrients, organelles, and proteins along their entire length. Disrupted protein synthesis and cellular stress can interfere with these transport systems, leading to “dying-back” neuropathy that starts distally and moves upward. NCBI+1

8. Mitochondrial stress and energy failure
   Many axonal neuropathies involve mitochondrial dysfunction, because axons require a lot of energy. Although not unique to CMT2U, altered protein quality control from MARS mutations may increase mitochondrial stress, lowering energy supply in neurons and contributing to axonal damage. Wikipedia+1

9. Selective vulnerability of long peripheral nerves
   The longest nerves, especially those that reach the feet and lower legs, are usually affected first in CMT2U. Their great length makes them more sensitive to small defects in protein handling and transport, so even a modest molecular problem in MARS can manifest clinically in these nerves before others. NCBI+1

10. Damage to sensory neurons
    CMT2U causes pan-modal sensory loss, meaning vibration, touch, pain, and temperature sensations can all be reduced in a “glove and stocking” pattern. This reflects injury to sensory axons and their cell bodies in the dorsal root ganglia, driven by the same MARS-related mechanisms. MalaCards+1

11. Damage to motor neurons
    Motor fibers that control movement are also affected, leading to weakness and atrophy of distal muscles. The same axonal degeneration process that affects sensory nerves also damages motor axons, which explains the combination of weakness and sensory loss. Orpha.net+2MalaCards+2

12. Secondary demyelination from axonal loss
    Although CMT2U is classified as an axonal neuropathy, myelin-forming Schwann cells can be secondarily disturbed when their axons degenerate. This can cause some myelin thinning and slowing of conduction, but the primary problem remains the axon itself. PM&R KnowledgeNow+1

13. Genetic modifiers and background genes
    Other genes in a person’s genome may slightly change how the MARS mutation expresses itself, making disease milder or more severe. This idea of “genetic modifiers” is well described in CMT generally, although exact modifier genes for CMT2U are not yet fully known. PubMed+1

14. Age-related nerve vulnerability
    CMT2U often starts in late adulthood, suggesting that normal age-related decline in nerve repair and resilience interacts with the lifelong presence of the MARS mutation. As people get older, their ability to compensate for the molecular defect decreases, and symptoms appear or progress. Orpha.net+1

15. Metabolic stress as a worsening factor (not a primary cause)
    Conditions like diabetes, vitamin deficiencies, or thyroid disease do not cause CMT2U, but they can cause their own neuropathies. When they coexist with a MARS mutation, they may worsen nerve damage and make symptoms appear earlier or more severe. Doctors therefore check and treat these conditions to protect remaining nerve function. MSD Manuals+1

16. Mechanical stress and entrapment neuropathies
    Repetitive pressure on nerves (for example at the ankle or wrist) does not cause CMT2U, but it can make symptoms worse in someone who already has fragile axons. This is why people with CMT are advised to avoid tight footwear and repetitive nerve compression when possible. MSD Manuals+1

17. Impaired nerve regeneration
    In healthy people, peripheral nerves can slowly regenerate after injury. With an underlying MARS mutation, this repair process may be less effective, so small injuries that would normally heal can lead to permanent deficits over time. NCBI+1

18. Disrupted interaction between axons and Schwann cells
    Axons and Schwann cells constantly “talk” to each other using molecular signals. Abnormal proteins in axons due to the MARS mutation can disturb this cross-talk, which may further weaken both axons and their myelin support. NCBI+1

19. Mislocalization of MARS protein inside neurons
    Experimental work on MARS mutations suggests that mutant enzymes may not stay where they should inside cells. If they gather in the wrong place, they can interfere with many pathways, including stress responses and protein handling, adding to neuron injury. Institut Myologie+1

20. Endoplasmic reticulum stress and unfolded protein response
    When cells produce abnormal proteins, the endoplasmic reticulum activates an “unfolded protein response.” Chronic activation of this stress response can make neurons more likely to die. Although data are still limited for CMT2U, similar mechanisms are shown in other CMT forms, and likely contribute here as well. Wikipedia+1

Symptoms

People with CMT2U usually develop symptoms in a slow, step-by-step way. Many of the symptoms are similar to other forms of CMT2, but the late onset and combination of sensory loss with hand and leg weakness are characteristic. Orpha.net+2MalaCards+2

1. Weakness in feet and ankles
   One of the earliest signs is difficulty lifting the front of the foot, especially when walking. People may notice that they trip on small obstacles or drag their toes. This happens because the distal muscles that lift the foot become weak as the peroneal and anterior tibial nerves are affected. Muscular Dystrophy Association+1

2. Foot drop and high-stepping gait
   When ankle dorsiflexion becomes weak, the person may develop “foot drop.” To avoid tripping, they lift the knees higher with each step, creating a high-stepping or “steppage” gait. This abnormal walking pattern is typical for axonal CMT forms, including CMT2U. Muscular Dystrophy Association+1

3. Muscle wasting in lower legs (“stork legs”)
   Over time, the calf muscles shrink and look thin, while the upper legs may appear more normal. This gives a “stork leg” or “inverted champagne bottle” appearance. The muscle wasting reflects long-standing denervation from the affected motor axons. NCBI+1

4. Weakness in hands and fingers
   CMT2U often involves distal upper-limb muscles, so people may struggle with fine tasks such as buttoning shirts, turning keys, or writing. The small hand muscles lose bulk, and grip strength can be reduced. This hand involvement is particularly highlighted in descriptions of CMT2U. MalaCards+1

5. Numbness and reduced sensation in feet and hands
   Sensory symptoms usually start as tingling or “pins and needles” in the toes and soles, then slowly extend up the legs and later affect the hands. People may not feel light touch, vibration, or temperature well. This “glove and stocking” pattern matches the distal sensory axon loss. MalaCards+2Charcot-Marie-Tooth Association+2

6. Loss of balance and unsteady walking
   Because the person cannot feel the ground well and can also have weakness, balance becomes poor, especially in the dark or on uneven ground. They may sway or feel unsure when standing still with eyes closed, and falls can become more frequent. CMT Research Foundation+1

7. Neuropathic pain
   Many adults with CMT2U experience burning, stabbing, or electric-shock-like pain in the feet or legs. This neuropathic pain comes from damaged sensory nerves sending incorrect signals to the brain. It can be constant or triggered by touch and may greatly affect sleep and mood. MalaCards+1

8. Decreased or absent reflexes
   On neurological exam, ankle reflexes are typically absent and knee reflexes may be reduced. Reflexes require intact sensory and motor pathways, so axonal damage in CMT2U interrupts this loop, leading to weak or absent responses. MalaCards+1

9. Muscle cramps and spasms
   Some people report painful cramps in the calves, arches of the feet, or hands. These can be worse at night or after activity. Cramps are thought to come from unstable motor units and changes in the excitability of the motor neurons. NCBI+1

10. Fatigue with walking or hand use
    Even when muscles are not extremely weak, they tire quickly. A person may be able to walk short distances but feel heavy and exhausted after longer walks, or may need frequent breaks when using the hands. This functional fatigue reflects the reduced reserve of weakened muscles. NCBI+1

11. Foot deformities (pes cavus and hammer toes)
    Many CMT patients develop high arches (pes cavus) and curled toes due to long-term imbalance between weak and strong muscles around the foot. These deformities can appear in CMT2U as well and may add to pain and instability when standing or walking. Muscular Dystrophy Association+1

12. Difficulty with stairs and uneven ground
    As weakness and sensory loss progress, climbing stairs, walking on sand or gravel, or hiking on uneven paths becomes very hard. People may need handrails, walking aids, or orthotic supports to stay safe. CMT Research Foundation+1

13. Hand clumsiness and dropping objects
    Fine motor control relies on intact sensation and strong intrinsic hand muscles. In CMT2U, the combination of numb fingers and weak small muscles makes it easy to drop cups, phones, or small tools, and handwriting may become slow or untidy. MalaCards+1

14. Sensory loss up the legs and arms with time
    In later stages, sensory loss may progress from the feet to mid-calf or above, and from the hands toward the elbows. This length-dependent spread is typical for axonal neuropathies and matches the dying-back pattern of long sensory fibers. NCBI+1

15. Impact on daily living and mood
    Chronic pain, reduced mobility, and loss of hand function can limit work, hobbies, and social activities. People may feel frustrated, anxious, or low in mood. While this is not a direct nerve symptom, it is an important part of the overall burden of CMT2U and needs attention in care. Charcot-Marie-Tooth Association+1

Diagnostic tests

Physical examination

Doctors begin diagnosis by taking a detailed history and doing a full neurological examination. This helps them recognize the typical pattern of distal weakness and sensory loss and decide which specialized tests are needed. NCBI+1

1. General neurological examination
   The neurologist checks muscle strength, sensation, reflexes, coordination, and cranial nerves. In CMT2U, they often find distal muscle weakness, reduced or absent ankle reflexes, and a stocking-glove pattern of sensory loss, while the rest of the nervous system is usually normal. NCBI+1

2. Inspection of muscle bulk and deformities
   The doctor looks at the shape of the legs, feet, hands, and arms. Signs such as thin calves, wasted hand muscles, high arches, or hammer toes support the diagnosis of a long-standing peripheral neuropathy like CMT2U. Muscular Dystrophy Association+1

3. Gait and walking assessment
   Watching how the person walks is very important. The examiner may see a high-stepping gait, foot drop, or poor balance, especially when the patient walks on heels or toes. These findings help distinguish CMT from other causes of walking problems. Muscular Dystrophy Association+1

4. Reflex testing
   Using a reflex hammer, the doctor checks knee and ankle reflexes and sometimes upper-limb reflexes. In CMT2U, reflexes at the ankles are usually absent, and knee reflexes may be reduced, which fits with peripheral nerve damage rather than spinal cord disease. NCBI+1

Manual bedside tests

These are simple tests the doctor does by hand, often during the same visit as the physical exam. They help map out weakness and sensory changes in more detail. NCBI+1

5. Manual muscle strength testing (MRC scale)
   The examiner asks the patient to move joints against resistance and grades strength on a scale from 0 to 5. In CMT2U, scores are often reduced (for example 3 or 4) in ankle dorsiflexion and finger or intrinsic hand muscles, while more proximal muscles may be near normal. NCBI+1

6. Vibration sense testing with a tuning fork
   A vibrating tuning fork is placed on the toes and ankles to see how long the patient can feel the vibration. People with CMT2U often lose vibration sense early, and this simple test is a sensitive way to detect large-fiber sensory loss. NCBI+1

7. Light touch and pinprick mapping
   The doctor gently touches the skin with cotton or a soft brush and uses a pin or neurotip for sharper stimuli, asking the patient what they feel. Reduced perception in a stocking-glove pattern supports a length-dependent axonal neuropathy. NCBI+1

8. Joint position (proprioception) testing
   The examiner moves the patient’s toes or fingers up and down with eyes closed and asks which way they moved. People with CMT2U may struggle to tell the direction, showing loss of position sense, which contributes to balance problems. CMT Research Foundation+2Charcot-Marie-Tooth Association+2

9. Balance tests (Romberg and tandem gait)
   In the Romberg test, the patient stands with feet together and eyes closed; swaying or falling suggests sensory ataxia. Tandem gait (heel-to-toe walking in a straight line) tests more advanced balance. These bedside tests show how much the sensory loss affects postural control. PM&R KnowledgeNow+1

Lab and pathological tests

Laboratory and genetic tests help confirm CMT2U, identify the exact gene mutation, and rule out other treatable causes of neuropathy. NCBI+1

10. Targeted MARS gene sequencing
    Once an inherited axonal neuropathy is suspected, genetic testing can look specifically at the MARS gene. Finding a known pathogenic mutation in a person with typical CMT2U symptoms gives a firm diagnosis and allows testing of relatives who may be at risk. ZFIN+2Global Genes+2

11. Hereditary neuropathy gene panel
    Many centers use next-generation sequencing panels that include dozens of CMT-related genes. This is useful when the clinical picture is not completely typical or when doctors want to rule out other CMT2 subtypes. Identifying a MARS mutation among many genes confirms that the subtype is CMT2U. PubMed+2NCBI+2

12. Basic blood tests to rule out acquired neuropathies
    Blood tests such as fasting glucose or HbA1c (for diabetes), vitamin B12, folate, thyroid-stimulating hormone, liver and kidney function, and sometimes autoimmune markers are done to exclude other causes of neuropathy. Normal results with a strong family history support a hereditary cause like CMT2U. MSD Manuals+1

13. Nerve biopsy (rarely needed)
    In the past, doctors sometimes removed a small piece of a sensory nerve (usually the sural nerve) to look at it under a microscope. Today, genetic testing has largely replaced nerve biopsy in CMT. Biopsy may still be used in unclear cases and would show axonal loss with secondary myelin changes in CMT2U. PM&R KnowledgeNow+1

14. Skin biopsy to study small nerve fibers (specialized centers)
    In some research or specialty settings, a skin biopsy is used to measure the density of small nerve fibers in the skin. Reduced fiber density would support peripheral neuropathy, but this test is not specific for CMT2U and is usually reserved for complex cases. NCBI+1

Electrodiagnostic tests

Electrodiagnostic tests are key tools for confirming that the neuropathy is axonal and for distinguishing CMT2U from demyelinating forms like CMT1 or from other motor neuron or muscle diseases. PM&R KnowledgeNow+1

15. Nerve conduction studies (NCS)
    NCS measure how fast and how strongly electrical signals travel along peripheral nerves. In CMT2U and other CMT2 forms, conduction velocity is usually normal or only mildly reduced, but the size (amplitude) of responses is low or absent, showing axonal loss. This pattern helps classify the neuropathy as axonal. PM&R KnowledgeNow+1

16. Electromyography (EMG)
    EMG uses a needle electrode in muscles to record their electrical activity. In CMT2U, EMG typically shows signs of chronic denervation and reinnervation, such as large motor unit potentials and reduced recruitment, especially in distal muscles. This confirms that the problem is in the peripheral motor axons rather than the muscle itself. PM&R KnowledgeNow+1

17. F-waves and late responses
    F-wave studies assess conduction along the whole length of motor nerves, including the segments near the spinal cord. In axonal neuropathies, F-wave amplitudes may be reduced or absent when many motor axons are lost. These findings add extra support for a diffuse peripheral neuropathy. PM&R KnowledgeNow+1

18. Somatosensory evoked potentials (SSEPs)
    SSEPs measure the brain’s response to stimulation of a peripheral nerve, such as at the wrist or ankle. In CMT2U, responses may be delayed or reduced, reflecting damage to sensory pathways. This test is not always necessary but can be helpful in complex diagnostic situations. PM&R KnowledgeNow+1

Imaging tests

Imaging is not used to “see” CMT2U directly but helps rule out other structural problems, understand deformities, and sometimes explore nerve anatomy. NCBI+1

19. MRI of the spine and plexus (to rule out other causes)
    Magnetic resonance imaging (MRI) of the lumbosacral spine or brachial plexus may be done if there is concern about spinal cord compression, tumors, or inflammatory diseases. A normal MRI in someone with a family history and typical nerve studies strengthens the diagnosis of hereditary axonal neuropathy such as CMT2U. MSD Manuals+1

20. X-rays of feet and ankles
    Simple X-rays can show high arches, hammer toes, and other bone and joint changes caused by long-term muscle imbalance in CMT. These images help orthopedic teams plan braces or surgery if needed and document how far deformities have progressed. Although X-rays cannot diagnose CMT2U alone, they are part of the overall evaluation in many patients. Muscular Dystrophy Association+1

Non-pharmacological treatments

These treatments do not use medicines but can strongly support people living with CMT2U.

1. Individualized physical therapy program
   A physical therapist creates a gentle exercise plan to keep muscles working and joints flexible. It usually includes stretching, strengthening, balance drills, and walking practice. Purpose: maintain mobility, reduce stiffness, and delay contractures. Mechanism: repeated, safe movement helps nerves use remaining connections efficiently and prevents muscles and tendons from shortening.Physiopedia+2Charcot-Marie-Tooth Association+2

2. Strength training with low resistance
   Simple exercises using body weight, light bands, or small weights help keep muscles around ankles, knees, and wrists as strong as possible. Purpose: support weak nerves by maximizing muscle power. Mechanism: gradual overload encourages surviving muscle fibers to grow larger and work more efficiently without over-tiring the damaged nerves.ScienceDirect+1

3. Balance and gait training
   Many people with CMT2U have poor balance and a high risk of falls. Therapists use stepping, standing, and walking tasks on safe surfaces to train balance. Purpose: reduce falls and build confidence in walking. Mechanism: repeated practice improves how the brain uses vision and remaining sensation to control body position.MDPI+1

4. Stretching and contracture prevention
   Daily stretching of calves, hamstrings, toes, and fingers helps prevent tendons from shortening. Purpose: reduce painful stiffness and keep joints moving. Mechanism: stretching slows down contracture formation that often appears when muscles are weak and cannot fully move a joint.Physiopedia+1

5. Ankle-foot orthoses (AFOs)
   Light plastic or carbon-fiber braces support weak ankles and lift the front of the foot (foot-drop), making walking safer and less tiring. Purpose: prevent tripping, improve foot clearance, and support deformed feet. Mechanism: the brace holds the ankle in a better position and substitutes for weak muscles.PMC+2ScienceDirect+2

6. Custom shoes and insoles
   Many people develop high arches or clawed toes. Special shoes with wide toe boxes and insoles that support the arch and heel reduce pressure points. Purpose: reduce pain and skin breakdown and make walking more stable. Mechanism: redistributing weight under the foot protects fragile areas and improves alignment.Physiopedia+1

7. Occupational therapy for hand function
   Occupational therapists teach hand and finger exercises, plus techniques to make daily tasks easier (button hooks, thick pens, adapted cutlery). Purpose: preserve independence in self-care, writing, phone use, and work. Mechanism: task-specific practice and adaptive tools reduce the effort needed from weak hand muscles.Charcot-Marie-Tooth Association+1

8. Assistive devices for mobility
   Canes, trekking poles, walkers, or wheelchairs may be used at different stages. Purpose: increase safety and reduce fatigue when walking long distances or on uneven ground. Mechanism: giving extra support lowers load on weak leg muscles and helps prevent falls.ScienceDirect+1

9. Home safety modifications
   Simple changes such as removing loose rugs, adding grab bars, using night lights, and putting handrails on stairs make the home safer. Purpose: prevent falls and injuries for people with poor sensation and balance. Mechanism: reducing environmental hazards compensates for nerve and muscle problems.ScienceDirect+1

10. Energy-conservation and fatigue management
    Therapists teach how to plan the day, spread tasks, and use rest breaks. Purpose: manage chronic tiredness, which is common in CMT. Mechanism: pacing and prioritizing activities prevent over-use of weak muscles and reduce pain flare-ups.ScienceDirect+1

11. Podiatry care
    Regular visits to a podiatrist for nail trimming, callus care, and footwear advice protect numb feet. Purpose: avoid ulcers, infections, and pain from pressure points. Mechanism: early care of small problems in insensate feet prevents serious complications.ScienceDirect+1

12. Pain psychology and cognitive-behavioral therapy (CBT)
    Chronic neuropathic pain can be emotionally exhausting. CBT and pain-coping training help people reframe thoughts, improve sleep, and manage stress. Purpose: reduce the suffering linked to pain even when pain is not fully removed. Mechanism: changing thought patterns alters how the brain processes pain signals.ScienceDirect+1

13. Support groups and patient organizations
    Groups such as CMT foundations allow people to share experiences, tips, and emotional support. Purpose: reduce isolation and give practical advice about living with CMT2U. Mechanism: peer support improves mood and encourages better self-management.Genetic Diseases Center+1

14. Genetic counseling for family planning
    Because CMT2U is autosomal dominant, genetic counselors explain inheritance, testing options, and pregnancy choices. Purpose: help families make informed decisions about having children. Mechanism: understanding the 50% transmission risk guides testing and planning.Orpha.net+1

15. Weight management and gentle aerobic exercise
    Activities like walking in a pool, cycling, or slow walking help maintain a healthy weight. Purpose: reduce joint stress and improve heart and lung health. Mechanism: controlled aerobic exercise increases endurance without over-taxing weak muscles.ScienceDirect+1

16. Ergonomic changes at school or work
    Adjustable chairs, key-boards, voice-to-text software, and flexible schedules can keep people productive longer. Purpose: maintain education and employment despite muscle weakness or fatigue. Mechanism: reducing physical strain allows limited strength to last through the day.ScienceDirect+1

17. Orthopedic monitoring of foot and spine alignment
    Regular review by an orthopedic specialist detects deformities early. Purpose: plan braces or minor procedures before deformities become fixed. Mechanism: early intervention reduces later need for big surgeries.Charcot-Marie-Tooth Disease+1

18. Respiratory and sleep assessment (if needed)
    Some CMT types can rarely affect breathing or cause sleep apnea. Testing helps if symptoms like snoring or morning headaches appear. Purpose: ensure good oxygen levels and sleep quality. Mechanism: CPAP or other supports keep airways open during sleep.ScienceDirect+1

19. Mental health support (counseling or therapy)
    Living with a chronic, slowly progressive disease can cause anxiety or low mood. Purpose: improve emotional resilience and coping skills. Mechanism: therapy helps people process feelings and build problem-solving strategies.ScienceDirect+1

20. Education about neurotoxic drugs and lifestyle risks
    Patients learn which medicines and habits can worsen neuropathy (for example, some chemotherapy drugs, excess alcohol). Purpose: avoid extra damage to already fragile nerves. Mechanism: avoiding neurotoxins protects remaining nerve fibers and slows worsening.ScienceDirect+1

---

Drug treatments

There are no drugs approved specifically for CMT2U. Medicines are used off-label to treat neuropathic pain, cramps, mood problems, and sleep issues. Always follow local guidelines and your doctor’s advice.PMC+2ScienceDirect+2

1. Gabapentin (Neurontin, Gralise, Horizant)
   Gabapentin is an anti-seizure medicine widely used for nerve pain. Typical adult doses for neuropathic pain are built slowly from 300 mg/day up to 900–3600 mg/day in divided doses, adjusted for kidney function. Purpose: reduce burning, stabbing neuropathic pain. Mechanism: it binds to calcium channels in nerve cells and reduces release of pain-signaling chemicals. Common side effects include sleepiness, dizziness, and swelling of legs.FDA Access Data+5FDA Access Data+5FDA Access Data+5

2. Pregabalin (Lyrica, Lyrica CR)
   Pregabalin is a related drug for neuropathic pain in diabetes, spinal cord injury, and post-herpetic neuralgia. Usual doses are 150–600 mg/day in 2–3 divided doses, adjusted for kidneys. Purpose: improve nerve pain and sleep. Mechanism: similar to gabapentin, it calms over-active pain pathways. Side effects include dizziness, weight gain, swelling, blurred vision, and drowsiness.FDA Access Data+5FDA Access Data+5FDA Access Data+5

3. Duloxetine (Cymbalta)
   Duloxetine is an antidepressant that also treats diabetic peripheral neuropathic pain and chronic pain. Usual starting dose for neuropathic pain is 30 mg once daily, increasing to 60 mg/day if tolerated. Purpose: reduce pain and improve mood. Mechanism: it increases serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord. Side effects include nausea, dry mouth, sleepiness, sweating, and sometimes raised blood pressure.FDA Access Data+6FDA Access Data+6FDA Access Data+6

4. Amitriptyline
   Amitriptyline is a tricyclic antidepressant often used at low doses for neuropathic pain. Typical bedtime doses start around 10–25 mg and may increase slowly to 75–100 mg if needed. Purpose: improve pain and sleep. Mechanism: blocks re-uptake of serotonin and norepinephrine and affects pain pathways. Side effects can include dry mouth, constipation, weight gain, drowsiness, and heart rhythm changes in some people.ScienceDirect+1

5. Nortriptyline
   Nortriptyline is similar to amitriptyline but sometimes better tolerated. Doses for pain often range from 10–75 mg at night. Purpose: help neuropathic pain and improve sleep. Mechanism: enhances pain-blocking neurotransmitters in the brain. Side effects: dry mouth, dizziness, constipation, and possible heart rhythm effects, especially in older adults.ScienceDirect

6. Venlafaxine (extended-release)
   Venlafaxine is another antidepressant used off-label for neuropathic pain. Doses often range from 75–225 mg/day in divided or extended-release form. Purpose: treat both pain and depression or anxiety. Mechanism: boosts serotonin and norepinephrine, helping the brain dampen pain signals. Common side effects include nausea, sweating, and increased blood pressure.ScienceDirect+1

7. Topical lidocaine 5% patch
   Lidocaine patches are placed on painful skin areas, usually up to 12 hours on and 12 hours off each day. Purpose: relieve localized burning or allodynia. Mechanism: blocks sodium channels in local nerve endings so fewer pain signals reach the brain. Side effects are usually mild skin irritation or redness.ScienceDirect+1

8. Topical capsaicin (cream or high-dose patch)
   Capsaicin from chili peppers is used on painful areas. Low-strength creams are applied several times a day; special high-dose patches are used in clinics. Purpose: reduce localized neuropathic pain. Mechanism: over-stimulates and then depletes substance P and other pain mediators in local nerve endings. It can cause burning or stinging at first.ScienceDirect+1

9. Tramadol (short-term use)
   Tramadol is a weak opioid with effects on serotonin and norepinephrine. Low doses (for example 50–100 mg every 6–8 hours, with maximum limits) may be used for short periods if other medicines fail. Purpose: manage severe pain spikes. Mechanism: binds to opioid receptors and modifies pain pathways. Side effects include nausea, dizziness, constipation, and dependence risk, so it must be used carefully.ScienceDirect+1

10. Classic non-steroidal anti-inflammatory drugs (NSAIDs)
    Medicines like ibuprofen or naproxen help with musculoskeletal pain from over-worked joints or muscles, even if they do not strongly treat nerve pain. Purpose: reduce aching after activity or minor injuries. Mechanism: block cyclo-oxygenase enzymes and lower prostaglandin levels that cause inflammation. Side effects include stomach irritation and kidney effects, especially with long-term use.ScienceDirect+1

11. Muscle relaxants (e.g., baclofen, tizanidine – if cramps are present)
    Some people with neuropathy experience painful cramps. Low doses of these medicines may be used to relax over-active muscles. Purpose: lessen cramps and spasms. Mechanism: they act on the spinal cord or muscle receptors to reduce abnormal muscle contractions. Side effects can include drowsiness and weakness, so careful dosing is essential.ScienceDirect+1

12. Sleep medicines in selected cases (e.g., low-dose melatonin, short-term hypnotics)
    Chronic pain may disturb sleep. In some people, short-term sleep medicines or melatonin help break a bad cycle. Purpose: improve restorative sleep. Mechanism: these drugs act on brain receptors that control sleep-wake cycles. Side effects vary but can include next-day drowsiness or dependence with some drugs.ScienceDirect

13. Selective serotonin reuptake inhibitors (SSRIs)
    For people with strong depression or anxiety related to CMT2U, SSRIs like sertraline or citalopram may be used. Purpose: improve mood and coping; sometimes indirectly improve pain tolerance. Mechanism: increase serotonin levels, which also influence pain pathways. Side effects include stomach upset and sleep changes.ScienceDirect+1

14. Alpha-lipoic acid (as a “drug-like” supplement in some countries)
    In some regions, alpha-lipoic acid is licensed as a medicine for diabetic neuropathy rather than as a supplement. Typical doses used in studies are 600 mg/day. Purpose: reduce neuropathic symptoms and oxidative stress. Mechanism: acts as an antioxidant and may improve nerve blood flow and glucose handling. Side effects are usually mild stomach upset.ScienceDirect

15. Vitamin B12 injections (when deficient)
    If blood tests show low B12, intramuscular injections are given, often 1 mg several times in the first weeks and then monthly, depending on guidelines. Purpose: correct deficiency that can worsen neuropathy. Mechanism: B12 is needed for myelin production and DNA repair in nerves. Side effects are rare, mostly mild injection-site pain.ScienceDirect+1

16. Vitamin D (prescription strength for deficiency)
    High-dose vitamin D can be prescribed to correct low levels. Purpose: support bone health and possibly muscle function. Mechanism: improves calcium balance and muscle performance, which indirectly helps mobility. Side effects are rare at correct doses but high doses can cause high calcium.ScienceDirect+1

17. Opioid medicines (only in special cases)
    Stronger opioids (like morphine or oxycodone) are rarely needed and used only for severe pain that does not respond to other options. Purpose: short-term relief of extreme pain. Mechanism: bind to opioid receptors in the brain and spinal cord. Side effects include constipation, drowsiness, and high addiction risk, so they are a last resort under close supervision.ScienceDirect+1

18. Anti-spasticity benzodiazepines (e.g., clonazepam – if other options fail)
    In some rare cases with painful myoclonus or severe cramps, clonazepam may be considered. Purpose: reduce involuntary movements and improve sleep. Mechanism: enhances GABA activity in brain circuits. Side effects include sedation, memory problems, and dependence, so long-term use is discouraged.ScienceDirect+1

19. Topical NSAID gels for joint pain
    When joints or tendons around weak muscles are inflamed, topical diclofenac gel can be applied. Purpose: local pain relief with lower overall drug exposure. Mechanism: reduces prostaglandins in the tissues under the skin. Side effects are usually local skin irritation.ScienceDirect

20. Combination therapy (e.g., gabapentin + antidepressant)
    Sometimes doctors use low doses of two medicines instead of a high dose of one. Purpose: better pain control with fewer side effects. Mechanism: different drugs act on different parts of pain pathways, so the combined effect can be stronger. Side effects depend on the medicines used and must be monitored carefully.ScienceDirect+1

Never start, stop, or change doses of any medicine without the guidance of a qualified doctor, especially for a rare disease like CMT2U.

---

Dietary molecular supplements

Evidence for supplements in CMT2U is limited, and they do not replace medical treatment. They are sometimes used to support general nerve health. Always ask your doctor first.ScienceDirect+1

1. Alpha-lipoic acid (ALA) – Often 300–600 mg/day. Function: antioxidant that may protect nerves from oxidative stress and improve blood flow. Mechanism: ALA works in mitochondria to recycle other antioxidants like vitamins C and E and can support glucose handling, which may reduce nerve damage in diabetic neuropathy; similar principles are sometimes applied to inherited neuropathies.ScienceDirect

2. Acetyl-L-carnitine – Common doses 500–1000 mg 1–2 times daily. Function: supports energy production in nerve cells. Mechanism: helps transport fatty acids into mitochondria, which may support regeneration and reduce pain in some neuropathy studies.ScienceDirect

3. Coenzyme Q10 (CoQ10) – Doses often 100–300 mg/day. Function: antioxidant and energy helper in mitochondria. Mechanism: participates in the electron transport chain and may improve energy production in muscles and nerves, with some data in mitochondrial diseases and heart failure.ScienceDirect+1

4. Vitamin B-complex (B1, B6, B12) – Taken at standard or slightly higher doses as advised. Function: support nerve conduction and myelin maintenance. Mechanism: B1 helps energy metabolism, B6 is involved in neurotransmitter synthesis (but excess B6 can itself cause neuropathy), and B12 is key for myelin repair; together they support healthy nerve function.ScienceDirect

5. Vitamin D – Dose depends on blood level (for example, 800–2000 IU/day if low). Function: supports bone and muscle health, reduces fracture risk in people with falls. Mechanism: regulates calcium and phosphate balance and may improve muscle strength, helping people with neuropathy stay mobile.ScienceDirect+1

6. Omega-3 fatty acids (fish oil or algae oil) – Typical total EPA+DHA 500–1000 mg/day. Function: anti-inflammatory and possibly neuroprotective. Mechanism: omega-3s integrate into nerve cell membranes and can reduce inflammatory mediators, which may indirectly protect nerves and improve cardiovascular health.ScienceDirect

7. Magnesium – Commonly 200–400 mg elemental magnesium/day if diet is low. Function: supports muscle relaxation and nerve signaling. Mechanism: acts as a co-factor in many enzymatic reactions and helps regulate calcium movement across nerve and muscle cell membranes, which may reduce cramps.ScienceDirect

8. Curcumin (from turmeric) – Doses in studies vary (often 500–1000 mg/day of standardized extract). Function: anti-inflammatory and antioxidant support. Mechanism: reduces activity of NF-κB and other inflammatory pathways, possibly protecting nerves from chronic low-grade inflammation.ScienceDirect

9. N-acetylcysteine (NAC) – Often 600–1200 mg/day in studies. Function: antioxidant and precursor to glutathione. Mechanism: provides cysteine for glutathione production, boosting the cell’s main antioxidant system and potentially limiting oxidative damage in nerve cells.ScienceDirect

10. Probiotics (gut microbiome support) – Specific doses depend on product. Function: support gut health and possibly reduce systemic inflammation. Mechanism: healthy gut bacteria can modulate immune responses and inflammation, which may indirectly benefit people with chronic neurological diseases.ScienceDirect+1

---

Immunity-booster and regenerative / stem-cell-related drugs

Right now, there are no approved immune-booster or stem cell drugs that specifically regenerate nerves in CMT2U. The approaches below are research concepts or used in other conditions, not standard treatment. Dosing is set only inside clinical trials or for other diseases.ResearchGate+3PMC+3ScienceDirect+3

1. Experimental gene therapy targeting MARS or related pathways
   Researchers are exploring gene therapy to correct or silence faulty genes in several CMT types. In the future, similar methods might target MARS mutations in CMT2U. Purpose: fix the basic genetic error. Mechanism: viral vectors or other tools deliver a healthy gene copy or editing system to nerve cells, aiming to restore normal protein function.

2. Neurotrophic factors (e.g., NGF, BDNF – experimental)
   Neurotrophic factors are proteins that help nerves survive and grow. Purpose: support existing nerve fibers and encourage regeneration. Mechanism: they bind to receptors on neurons and turn on survival and growth pathways. So far, trials in peripheral neuropathies have been limited by side effects and delivery challenges.ScienceDirect

3. Mesenchymal stem cell therapies (research)
   In some small studies of other neuropathies, mesenchymal stem cells are given intravenously or locally. Purpose: modulate immunity and release growth factors. Mechanism: these cells may reduce inflammation and release substances that support nerve repair, but evidence in CMT is still weak, and treatments outside trials can be risky and expensive.ScienceDirect+1

4. Induced pluripotent stem cell (iPSC)–based strategies
   Scientists can create iPSCs from a patient’s own cells and turn them into nerve cells in the lab. Purpose: model CMT2U and test future drugs. Mechanism: iPSC-derived neurons carry the same MARS mutation, helping researchers understand disease mechanisms and screen compounds that might be regenerative.SAGE Journals+1

5. Immune-modulating drugs in overlap conditions
   If someone with CMT2U also has an inflammatory neuropathy, immune therapies (like IVIG or steroids) may be used for that separate condition, not for CMT2U itself. Purpose: control autoimmune damage. Mechanism: IVIG and steroids calm down an over-active immune system that attacks nerves. They do not repair the genetic CMT2U neuropathy.ScienceDirect+1

6. Lifestyle-based “immune support” (sleep, exercise, vaccines)
   Good sleep, moderate exercise, stress control, and recommended vaccinations help the immune system work properly. Purpose: reduce infections and general illness burden. Mechanism: healthy lifestyle and vaccines reduce preventable infections that could worsen weakness and mobility in people with CMT2U.ScienceDirect+1

---

Surgeries for CMT2U

Surgery does not cure CMT2U, but it can correct fixed deformities and improve walking when bracing is not enough.Charcot-Marie-Tooth Disease+1

1. Soft-tissue procedures (tendon releases and lengthening)
   Surgeons may lengthen tight Achilles tendons or release contracted plantar fascia in the foot. Why done: to reduce toe clawing, improve ankle movement, and allow the foot to rest more flat on the ground, making brace fitting easier and walking more stable.

2. Tendon transfers
   Stronger tendons can be moved to replace the function of very weak muscles, for example to lift the foot and reduce foot-drop. Why done: to rebalance forces around the ankle, improve swing-phase foot clearance, and delay more major bone surgeries.Charcot-Marie-Tooth Disease+1

3. Osteotomies (bone-cutting surgeries)
   When the foot has become rigidly deformed (very high arch, heel twisted in or out), surgeons may cut and re-position bones in the mid-foot or heel. Why done: to create a more neutral, plantigrade foot that fits shoes and braces and spreads pressure more evenly.Charcot-Marie-Tooth Disease+1

4. Joint fusion (arthrodesis)
   If joints are severely deformed and painful, surgeons may fuse them in a better position. Why done: to remove deforming movement and pain when joints are already stiff and damaged, trading some motion for better stability and less pain.

5. Nerve decompression (selective cases)
   In rare situations, nerves already damaged by CMT may also be compressed by tight tunnels (like carpal tunnel in the wrist). Why done: releasing the tunnel may relieve extra pressure and improve symptoms from the compression, even if it cannot reverse the underlying CMT2U neuropathy.Medscape eMedicine+1

---

Preventions

CMT2U cannot be prevented because it is genetic, but many complications can be reduced:ScienceDirect+1

1. Avoid medicines known to be toxic to peripheral nerves whenever possible (for example, some chemotherapy agents; your neurologist will advise).

2. Limit alcohol, which can damage nerves and worsen balance.

3. Maintain a healthy weight to reduce stress on weak feet, ankles, and knees.

4. Use appropriate braces, shoes, and walking aids early, not late, to prevent falls and deformity.

5. Do regular stretching and strengthening exercises to delay contractures.

6. Protect numb feet with daily inspection, proper socks, and podiatry visits.

7. Keep diabetes, thyroid problems, and vitamin deficiencies well controlled if present.

8. Stop smoking, which reduces blood flow to nerves and muscles.

9. Make home and work environments safe (good lighting, handrails, non-slip surfaces).

10. Attend regular follow-ups with neurology and rehabilitation teams to adjust treatments as the disease slowly progresses.

---

When to see doctors

See a doctor or specialist promptly if:Genetic Diseases Center+2ScienceDirect+2

• You notice new weakness, tripping, or difficulty with buttons or writing.

• Numbness, burning, or electric-shock pain in feet or hands starts or suddenly worsens.

• You develop changes in foot shape, severe calluses, or ulcers that do not heal.

• Walking becomes unsafe and you have frequent falls.

• You experience breathing problems, sleep disturbance, or morning headaches.

• Mood changes, anxiety, or depression feel overwhelming.

• You plan a pregnancy or want to discuss genetic risks with a counselor.

Emergency care is needed if you have sudden severe weakness, trouble breathing, chest pain, or a serious fall with head injury.

---

What to eat and what to avoid

Diet cannot cure CMT2U, but it supports general nerve and muscle health.ScienceDirect+1

1. Eat plenty of colorful vegetables and fruits – They provide antioxidants that help protect cells, including nerve cells, from oxidative stress.

2. Choose whole grains (brown rice, oats, whole-wheat bread) – They give steady energy and important B-vitamins.

3. Include lean proteins (fish, eggs, beans, lentils, poultry) – They supply amino acids to maintain muscles and repair tissues.

4. Add healthy fats (nuts, seeds, olive oil, fatty fish) – Omega-3 fats may reduce inflammation and support nerve membranes.

5. Ensure enough B-vitamins and B12 – Through foods like eggs, dairy, meat, or fortified cereals; ask about supplements if you are vegetarian or have absorption issues.

6. Maintain good vitamin D and calcium intake – Dairy, fortified plant milks, and safe sun exposure help keep bones strong.

7. Limit sugary drinks and ultra-processed snacks – They promote weight gain and inflammation, which can worsen mobility problems.

8. Avoid heavy alcohol use – Alcohol can directly damage nerves and worsen balance and falls.

9. Watch salt and saturated fats – This helps protect heart and blood vessels, important for long-term health in people with reduced activity.

10. Stay well hydrated – Enough water helps overall health, bowel function, and may reduce cramps in some people.

---

Frequently asked questions

1. Is CMT2U curable?
   No. At present there is no cure or disease-modifying drug for autosomal dominant axonal CMT2U. Treatment focuses on symptoms, mobility, and quality of life through rehabilitation, orthotics, and carefully selected medicines and surgeries.PMC+2ScienceDirect+2

2. What causes CMT2U?
   CMT2U is usually caused by mutations in the MARS gene, which codes for methionyl-tRNA synthetase. This enzyme is essential for building proteins in nerve cells. When it does not work properly, long axons in peripheral nerves gradually degenerate.Orpha.net+3SAGE Journals+3American Academy of Neurology+3

3. How is CMT2U different from other CMT types?
   CMT2U is an axonal type (CMT2), meaning the main damage is to the axon, not the myelin covering. It tends to have late adult onset and slowly progressive distal weakness and sensory loss. Other types may start in childhood or involve demyelination with different nerve test results.NCBI+2Orpha.net+2

4. What tests confirm CMT2U?
   Doctors use a mix of family history, neurological examination, nerve conduction studies, electromyography, and genetic testing focused on CMT genes (including MARS). Sometimes imaging or nerve biopsy may be used in complex cases.ScienceDirect+1

5. Does CMT2U shorten life expectancy?
   For most people, CMT2U is slowly progressive and mainly affects limbs, not vital organs. Many live a normal lifespan, although disability can increase with age. Severe complications like falls, fractures, or very rare breathing problems may affect health if not well managed.Orpha.net+1

6. Can exercise make CMT2U worse?
   Well-planned, low-to-moderate exercise usually helps rather than harms. Over-exertion that causes long-lasting pain or extreme fatigue should be avoided. A physical therapist familiar with CMT can design a safe plan.ScienceDirect+2MDPI+2

7. Are there special shoes for CMT2U?
   Yes. Supportive shoes with a firm heel counter, wide toe box, and room for insoles or AFOs are very helpful. An orthotist or podiatrist can advise on the best option for your foot shape and braces.Physiopedia+2Charcot-Marie-Tooth Disease+2

8. Will I need a wheelchair?
   Not everyone with CMT2U needs a wheelchair. Some people use one only for long distances to save energy; others may need one more often if leg weakness becomes severe. The goal is independence and safety, not “giving up.”ScienceDirect+1

9. Can children inherit CMT2U?
   Yes. Because it is autosomal dominant, each child of an affected parent has about a 50% chance of inheriting the mutation. Genetic counseling can help families understand options for testing and family planning.Orpha.net+2SAGE Journals+2

10. Is pregnancy safe with CMT2U?
    Many people with CMT carry pregnancies safely, but extra planning is helpful. Weakness, balance issues, and pain may worsen temporarily. Obstetricians and anesthesiologists should know about the neuropathy before labor and anesthesia decisions.ScienceDirect+1

11. What about anesthesia and surgery risks?
    Most people with CMT can have anesthesia, but the team needs to know about the neuropathy. Some drugs that strongly affect nerves or muscles are used cautiously. After surgery, careful positioning and nerve protection are important.Medscape eMedicine+1

12. Can diet alone treat CMT2U?
    No. Diet cannot repair genetic nerve damage. However, a balanced, nutrient-rich diet supports general health, weight control, and bone and muscle strength, which can make daily life with CMT2U easier.ScienceDirect+1

13. Are stem cell clinics advertised online safe for CMT2U?
    Most commercial stem cell clinics offering “cures” for neuropathy have little or no scientific proof and may be unsafe or extremely expensive. True stem cell research for CMT is still mainly in laboratories or carefully controlled trials.ResearchGate+1

14. How often should I follow up with doctors?
    Many experts recommend at least yearly review with a neurologist or multidisciplinary CMT clinic, plus more frequent visits with physical and occupational therapists, orthotists, and podiatrists depending on your needs.ScienceDirect+2ScienceDirect+2

15. What is the most important thing I can do now?
    The most helpful steps are: confirm the diagnosis with a specialist, stay active with safe exercise, use braces or aids when recommended, protect your feet, manage pain carefully, and keep a positive, informed relationship with your healthcare team. These actions help you live as fully and safely as possible with CMT2U.ScienceDirect+2ScienceDirect+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.